Short-term Outcomes of Minimally Invasive McKeown Procedure Versus Open Ivor-Lewis Procedure for Lower and Middle Esophageal Cancer
DOI:
https://doi.org/10.53469/jcmp.2024.06(07).29Keywords:
Minimally invasive McKeown procedure, Open Ivor-Lewis procedure, Esophageal cancer, Short-term outcomeAbstract
Objective: To compare the short-term efficacy of treating lower and middle esophageal cancer by thoracolaparoscopic minimally invasive McKeown radical esophagectomy with open Ivor-Lewis esophagectomy. Methods: Fifty-four patients with middle and lower esophageal cancer admitted to the Department of Thoracic Surgery and Department of Surgical Oncology of our hospital from January 2013 to December 2017 were reviewed, and were divided into 16 cases in the observation group, which underwent thoracolaparoscopic minimally invasive McKeown esophageal cancer radical operation, and 38 cases in the control group, which underwent open thoracic Ivor-Lewis esophageal cancer radical operation, according to different surgical methods. The perioperative indicators, postoperative complications, and quality of life scores of the two groups were compared. Results: Intraoperative bleeding, postoperative chest drainage, extubation time, venting time, and hospitalization time of the observation group were lower than those of the control group (P<0.05); and the number of cleared lymph nodes of the observation group was more than that of the control group (P<0.05). Comparing the VAS pain scores of the two groups on the 1st, 2nd and 3rd days of postoperative activity, the VAS score of the observation group was lower than that of the control group (P<0.05). Comparison of leukocyte count and C-reactive protein on the 1st and 7th postoperative days between the two groups, the observation group was lower than the control group (P<0.05). There were differences in the observation group in the occurrence of reflux gastritis, lung infection, anastomotic fistula, abnormal skin sensation and hoarseness compared with the control group (P<0.05). Comparing the quality of life scores of the two groups at 1 month after surgery, there was a difference between the observation group in somatic, role, emotional, and general function scores were better than the control group (P<0.05), while there was no statistical significance in cognitive and social function scores (P>0.05). Conclusion: Minimally invasive McKeown's procedure and open Ivor-Lewis's procedure can both be used as surgical procedures for the treatment of lower and middle esophageal cancer, Ivor-Lewis's procedure has a lower incidence of anastomotic fistula and laryngeal recurrent nerve paralysis, and is highly traumatizing; minimally invasive McKeown's procedure clears a larger number of lymph nodes, has a positive efficacy, is less traumatizing, has a quicker recovery, and has better short-term results.
References
F. Bray, M. Laversanne, H. Sung, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
H. Zhu, X. Ma, T. Ye, et al. Esophageal cancer in China: practice and research in the new era [J]. Int J Cancer, 2023, 152(9): 1741-1751.
F. Liu, W. Yang, W. Yang, et al. Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study [J]. Ann Surg, 2023, 277(4): e777-e784.
B. Li, J. Xiang, Y. Zhang, et al. Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial [ J]. JAMA Surg, 2015, 150(4): 292-298.
Y. Li, J. Xu, Y. Gu, et al. The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study [J]. JMIR Public Health Surveill, 2022, 8(3): e33191.
E. Morgan, I. Soerjomataram, H. Rumgay, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020 [J]. and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020 [J]. Gastroenterology, 2022, 163(3): 649-658 e642.
B. Li, Y. Zhang, L. Miao, et al. Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer. Long-Term Outcomes of a Randomized Clinical Trial [J]. J Thorac Oncol, 2021, 16(2): 310-317.
J. W. Cho, S. C. Choi, J. Y. Jang, et al. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View [J]. Clin Endosc, 2014, 47(6): 523-529.
T. W. Rice, H. Ishwaran, M. K. Ferguson, et al. Cancer of the Esophagus and Esophagogastric Junction: an Eighth Edition Staging Primer [J]. J Thorac Oncol, 2017, 12(1): 36-42.
M. C. Kalff, M. I. van Berge Henegouwen and S. S. Gisbertz Textbook outcome for esophageal cancer surgery: an international consensus-based update of an international consensus-based update of a quality measure [J]. Dis Esophagus, 2021, 34(7).
K. Gulben, F. Irkin, M. Yazi, et al. Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma [J]. Neoplasma, 2017, 64(1): 131-135.
J.B. Zuo, W.D. Qu, A.M. Zhou, et al. Systematic Evaluation and Meta-analysis of the Recent Efficacy of Thoracic Laparoscopy Combined with Ivor Lewis Surgery and McKeown Surgery for the Treatment of Lower and Middle Thoracic Esophageal Cancer [J]. Chinese Clinical Journal of Thoracic and Cardiovascular Surgery, 2017, 24(06): 456-462.
J. Nie, B. Zhou and L. Wang Effect of different lymph node dissection styles on recurrence rate of lymph node metastasis, survival time and complications in elderly patients with upper thoracic esophageal cancer [J]. Journal of Practical Cancer, 2017, 32(08): 1267-1269.
J.N. Xu and G Liu, F. Comparison of the effectiveness of thoracolaparoscopic Ivor-Lewis procedure and McKeown procedure in lower mid-thoracic esophageal cancer [J]. China Clinical Research, 2017, 30(09): 1219-1221.
C. T. Bakhos, S. C. Wang and J. M. Rosen Contemporary role of minimally invasive thoracic surgery in the management of pulmonary arteriovenous malformations: report of two cases and review of the literature [J]. J Thorac Dis, 2016, 8(1): 195-197.
Expert Committee on Rapid Rehabilitation of Thoracic Surgery Branch of Chinese Physicians Association. Expert consensus on the application of accelerated rehabilitation surgical techniques for esophageal cancer (2016 edition) [J]. Chinese Journal of Thoracic and Cardiovascular Surgery, 2016, 32(12): 717-722.
J. Zielinski, A. Ptach, A. Sadowski, et al. Multistage resection of esophageal squamous cell cancer of the cardia - successful despite complications [J]. Kardiochir Torakochirurgia Pol, 2015, 12(3): 255-258.
Y. Rong, Y.B. Hao, Y.M Li, et al. Comparison of safety and outcome between minimally invasive radical esophageal cancer surgery and conventional open-heart surgery for esophageal cancer [J]. Journal of Hebei Medical University, 2018, 39(02): 146-149,154.
A. Junttila, O. Helminen, M. Helmio, et al. Five-year Survival after McKeown Compared to Ivor-Lewis Esophagectomy for Esophageal Cancer: A Population-based Nationwide Study in Finland [J]. Ann Surg, 2023, 277(6): 964-970.
Z.L. Li, Y.X. Wang and J.Z. Zang Effects of different radical esophageal cancer treatments on patients' postoperative lung function and inflammatory factor levels [J]. Laboratory Medicine and Clinics, 2016, 13(06): 746-748.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jiaqi Yu, Yong Zhang
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
